GB2079289B - Process for preparing antibody - Google Patents

Process for preparing antibody

Info

Publication number
GB2079289B
GB2079289B GB8115648A GB8115648A GB2079289B GB 2079289 B GB2079289 B GB 2079289B GB 8115648 A GB8115648 A GB 8115648A GB 8115648 A GB8115648 A GB 8115648A GB 2079289 B GB2079289 B GB 2079289B
Authority
GB
United Kingdom
Prior art keywords
preparing antibody
antibody
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8115648A
Other languages
English (en)
Other versions
GB2079289A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of GB2079289A publication Critical patent/GB2079289A/en
Application granted granted Critical
Publication of GB2079289B publication Critical patent/GB2079289B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/822—Identified hapten
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/823—Immunogenic carrier or carrier per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB8115648A 1980-05-21 1981-05-21 Process for preparing antibody Expired GB2079289B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6804080A JPS56163456A (en) 1980-05-21 1980-05-21 Preparation of antigen

Publications (2)

Publication Number Publication Date
GB2079289A GB2079289A (en) 1982-01-20
GB2079289B true GB2079289B (en) 1983-10-26

Family

ID=13362282

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8115648A Expired GB2079289B (en) 1980-05-21 1981-05-21 Process for preparing antibody

Country Status (8)

Country Link
US (1) US4407965A (enExample)
JP (1) JPS56163456A (enExample)
BE (1) BE888906A (enExample)
DE (1) DE3120312C2 (enExample)
DK (1) DK159163C (enExample)
FR (1) FR2482861A1 (enExample)
GB (1) GB2079289B (enExample)
SE (1) SE454301B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1249395A (en) * 1982-09-30 1989-01-24 Tetsuya Tachikawa Human leukemia virus-related peptides, a process for production thereof, antibodies of the peptides and a process for production of the antibodies
CA1256795A (en) * 1983-12-28 1989-07-04 Dennis A. Carson Anti-idiotype antibodies induced by synthetic polypeptides
US4545985A (en) * 1984-01-26 1985-10-08 The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services Pseudomonas exotoxin conjugate immunotoxins
GB2160312B (en) * 1984-04-13 1987-09-16 South African Inventions Adjuvant for immunisation
US4654419A (en) * 1984-08-08 1987-03-31 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
US5116725A (en) * 1984-08-08 1992-05-26 Scripps Clinic And Research Foundation Assay for Epstein-Barr virus infection with solid phase bound synthetic polypeptides
WO1986001834A1 (en) * 1984-09-19 1986-03-27 The Regents Of The University Of California Retroviral polypeptides associated with human cellular transformation
US4732863A (en) * 1984-12-31 1988-03-22 University Of New Mexico PEG-modified antibody with reduced affinity for cell surface Fc receptors
JPH0792458B2 (ja) * 1986-03-14 1995-10-09 郁男 山科 糖鎖特異抗体アツセイプレ−ト及びその製造方法
US5202270A (en) * 1986-05-15 1993-04-13 Abbott Laboratories Cocaine and cocaine metabolites assay tracers, immunogens and antibodies
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
BR112017005110A2 (pt) 2014-09-16 2018-01-23 Regeneron Pharma anticorpo monoclonal isolado ou fragmento de ligação ao antígeno do mesmo, molécula isolada de ácido nucleico, composição farmacêutica, e, método para diminuir níveis de glicose no sangue ou para tratar uma condição ou doença.
JP7173962B2 (ja) 2016-08-30 2022-11-16 リジェネロン・ファーマシューティカルズ・インコーポレイテッド グルカゴン受容体シグナル伝達の干渉による重度のインスリン抵抗性の処置方法
US20190248888A1 (en) 2016-10-20 2019-08-15 Regeneron Pharmaceuticals, Inc. Methods of lowering blood glucose levels
CA3071387A1 (en) 2017-08-22 2019-02-28 Regeneron Pharmaceuticals, Inc. Methods of treating urea cycle disorders by interfering with glucagon receptor signaling

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5836308B2 (ja) * 1977-02-10 1983-08-08 大塚製薬株式会社 抗体の製造方法
US4206199A (en) * 1977-07-22 1980-06-03 Takeda Chemical Industries, Ltd. Novel glucagon fragment and its derivatives

Also Published As

Publication number Publication date
DK159163C (da) 1991-02-11
DE3120312A1 (de) 1982-03-04
DK159163B (da) 1990-09-10
DK222081A (da) 1981-11-22
US4407965A (en) 1983-10-04
FR2482861A1 (fr) 1981-11-27
SE454301B (sv) 1988-04-18
DE3120312C2 (de) 1985-08-29
JPS6223822B2 (enExample) 1987-05-25
GB2079289A (en) 1982-01-20
JPS56163456A (en) 1981-12-16
FR2482861B1 (enExample) 1983-09-09
BE888906A (fr) 1981-11-23
SE8103198L (sv) 1981-11-22

Similar Documents

Publication Publication Date Title
PT73817B (en) Process for preparing 2-guanidino-4-heteroarylthiazoles
PL234007A1 (en) Process for preparing novel imidazolylphenylamidines
PT73671B (en) Process for preparing isoxazolylbenzamides
GB2082172B (en) Process for preparing n-alkyl-alkylenediamines
YU164481A (en) Process for obtaining isoxazolyl-imidazolidinone
PT73211A (en) Process for preparing thiophenesulphonamides
YU141080A (en) Process for preparing n-chlorocarbonl-lactams
PT73288B (en) Process for preparing tylactone
PT72348B (en) Process for preparing kijanimicin
PT73383A (en) Process for preparing 1-chloro-1-p-methoxybenzoylformaldoxime- n-methil-carbamate
PT72840A (en) Process for preparing phenyl-quinolizidines
PL241645A1 (en) Process for preparing novel 2-guanidine-4-heteroarylothiazoles
PT72378B (en) Process for preparing substituted benzoni-triles
DE3161061D1 (en) Process for preparing arylacetaldehydes
PL232567A1 (en) Process for preparing 11-hydroxy-13-oxa-prostaglandin
IL70220A0 (en) Process for 1-oxa-beta-lactams
DE3161108D1 (en) Process for preparing cyclopentenolones
PT73645A (en) Process for preparing new 4-carbamoyloxy-oxazaphosphorins
DE3165126D1 (en) Process for preparing cyclopentenolones
PT72679A (en) Process for preparing 2-haloacetanilides
YU184881A (en) Process for obtaining 4-amino-12-dihydrocarbyl-pyrazolidine
DE3168346D1 (en) Process for preparing n-cyanolactames
DE3160081D1 (en) Process for preparing dimethyl-polysulfides
YU77880A (en) Process for preparing methyl-1-methyl-10-alpha-methoxy-dihydrolysergate
YU47680A (en) Process for preparing proscillaridin-4-methylether

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19980521